Dr Nicholas Welch
The success and viability of vital new implantable medical devices and cell therapies such as cochlear implants, indwelling medical sensors and diabetes islet cell treatment are severely hampered by the natural foreign body response (FBR) that result in the formation of a fibrotic capsule around the implant.
Dr Welch’s study mission aims to understand how to modulate and overcome this tissue response and develop new types of biomedical devices and therapies or provide important improvements in performance and longevity of existing devices.
The first applications will be in the treatment of diabetes with indwelling glucose sensors and implantable cell therapies for insulin production and in the electro-stimulation of nerve cells as with the cochlear ear implant.
Dr Welch, pictured here with AFAS President, Peter Tolé and AFAS Committee Member, Rackel San Nicolas, will travel to Switzerland, Germany, France and Greece to advance his research, .